The substance-exposed birthing person-infant/child dyad and health information exchange in the United States
- PMID: 39749875
- PMCID: PMC11833485
- DOI: 10.1093/jamia/ocae315
The substance-exposed birthing person-infant/child dyad and health information exchange in the United States
Abstract
Objective: Timely access to data is needed to improve care for substance-exposed birthing persons and their infants, a significant public health problem in the United States. We examined the current state of birthing person and infant/child (dyad) data-sharing capabilities supported by health information exchange (HIE) standards and HIE network capabilities for data exchange to inform point-of-care needs assessment for the substance-exposed dyad.
Material and methods: A cross-map analysis was performed using a set of dyadic data elements focused on pediatric development and longitudinal supportive care for substance-exposed dyads (70 birthing person and 110 infant/child elements). Cross-mapping was conducted to identify definitional alignment to standardized data fields within national healthcare data exchange standards, the United States Core Data for Interoperability (USCDI) version 4 (v4) and Fast Healthcare Interoperability Resources (FHIR) release 4 (R4), and applicable structured vocabulary standards or terminology associated with USCDI. Subsequent survey analysis examined representative HIE network sharing capabilities, focusing on USCDI and FHIR usage.
Results: 91.11% of dyadic data elements cross-mapped to at least 1 USCDI v4 standardized data field (87.80% of those structured) and 88.89% to FHIR R4. 75% of the surveyed HIE networks reported supporting USCDI versions 1 or 2 and the capability to use FHIR, though demand is limited.
Discussion: HIE of clinical and supportive care data for substance-exposed dyads is supported by current national standards, though limitations exist.
Conclusion: These findings offer a dyadic-focused framework for electronic health record-centered data exchange to inform bedside care longitudinally across clinical touchpoints and population-level health.
Keywords: United States Core Data for Interoperability (USCDI); birthing person-infant dyad; electronic health record (EHR); fast healthcare interoperability resources (FHIR); health information exchange (HIE); substance exposure.
Published by Oxford University Press on behalf of the American Medical Informatics Association 2025.
Conflict of interest statement
The authors have no competing interests to declare.
Figures




Similar articles
-
Electronic Health Record and Semantic Issues Using Fast Healthcare Interoperability Resources: Systematic Mapping Review.J Med Internet Res. 2024 Jan 30;26:e45209. doi: 10.2196/45209. J Med Internet Res. 2024. PMID: 38289660 Free PMC article.
-
A Unified Approach to Health Data Exchange: A Report From the US DHHS.JAMA. 2025 Mar 25;333(12):1074-1079. doi: 10.1001/jama.2025.0068. JAMA. 2025. PMID: 39826091 Free PMC article.
-
Standardizing imaging findings representation: harnessing Common Data Elements semantics and Fast Healthcare Interoperability Resources structures.J Am Med Inform Assoc. 2024 Aug 1;31(8):1735-1742. doi: 10.1093/jamia/ocae134. J Am Med Inform Assoc. 2024. PMID: 38900188 Free PMC article.
-
Minimal Common Oncology Data Elements Genomics Pilot Project: Enhancing Oncology Research Through Electronic Health Record Interoperability at Vanderbilt University Medical Center.JCO Clin Cancer Inform. 2024 Jun;8:e2300249. doi: 10.1200/CCI.23.00249. JCO Clin Cancer Inform. 2024. PMID: 38935887 Free PMC article.
-
A systematic review of data elements of computerized physician order entry (CPOE): mapping the data to FHIR.Inform Health Soc Care. 2023 Oct 2;48(4):402-419. doi: 10.1080/17538157.2023.2255285. Epub 2023 Dec 6. Inform Health Soc Care. 2023. PMID: 37723918
Cited by
-
Beyond the individual.J Am Med Inform Assoc. 2025 Mar 1;32(3):415-416. doi: 10.1093/jamia/ocaf020. J Am Med Inform Assoc. 2025. PMID: 39963970 No abstract available.
References
-
- Finnegan LP, Kron RE, Connaughton JF, Emich JP. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm. 1975;12:19-32. - PubMed